Engaging Diverse Underserved Communities to Bridge the Mammography Divide

Not Applicable

Completed

• Conditions: Breast Cancer Screening
• Interventions: Other: MI2 intervention arm; Other: Control

• Registration Number: NCT01267110
• Lead Sponsor: University of Kansas

Brief Summary

Breast cancer is the second most common cause of cancer death in the U.S.1 in spite of being preventable, easily detectable, and curable.2-11 Breast screening continues to be underutilized by the general population and especially by traditionally underserved minority populations. Two of the least screened minority groups are American Indians/Alaska Natives (AI/AN) and Latinas. American Indian/Alaska Native women have the poorest recorded 5-year cancer survival rates of any ethnic group and the lowest (or near-lowest) screening rates for major cancers.12 Furthermore, breast cancer is the number one cause of cancer mortality among Latina women.13 While breast cancer screening rates have increased nationally, there has been an increase in the gap in breast cancer screening utilization between individuals from minority versus majority racial/ethnic groups.

Detailed Description

If you decide to participate in the program, your participation will last 4 months. You will complete the Healthy Living Kansas-Breast Health survey by computer. The survey will take about 20 minutes to complete. You will be randomly assigned (like flipping a coin) to one of two groups. The groups will receive different breast health information. After completing the survey, you agree to be contacted by telephone in 4 months to answer questions. You will be asked for your name, home address, and phone number.

You will be given information about breast cancer and mammography. You may or may not benefit from the information provided. Care will be taken to safeguard the information you provide but under rare circumstances confidentiality breaches may occur.

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2010-12-21
• Study First Submitted QC: 2010-12-23
• Study First Posted: 2010-12-24
• Primary Completion: 2015-06
• Study Completion: 2015-08
• Status Verified: 2015-09
• Last Update Submitted: 2015-09-15
• Last Update Posted: 2015-09-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 261

Inclusion Criteria

• Latina or AI/AN woman residing in one of participating communities
• Aged ≥40 years of age
• Not up to date on mammography screening
• Home address & access to a working telephone
• Responded to 120-day post randomization follow-up call

Read More

Exclusion Criteria

• Receipt of mammogram within past year
• Acute medical illness, history of breast cancer, 1st
• Cognitive impairment or inappropriate affect or behavior
• Another household member enrolled in the study

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention	MI2 intervention arm	-
Control	Control	-

Primary Outcome Measures

Name	Time	Method
120-day post randomization mammography screening completion	day 120	To compare the 120-day post randomization mammography screening completion rates of individuals who receive a computerized mammography "implementation intentions" (MI2) intervention, versus a comparison computerized condition of general breast cancer prevention health education (C).

Secondary Outcome Measures

Name	Time	Method
To compare the screening mammography self-reported barriers after 120-days post randomization	day 120	To compare the screening mammography self-reported barriers after 120-days post randomization between those receiving a mammography "implementation intentions" intervention (MI2) and those receiving only a general breast cancer prevention health education intervention (C).
To compare changes in mammography screening Precaution Adoption Process Model	day 120	To compare changes in mammography screening Precaution Adoption Process Model decisional stage from baseline to 120 days post randomization between individuals in the MI2 and C study arms.

Trial Locations

Locations (1)

University of Kansas Medical Center; 🇺🇸 Kansas City, Kansas, United States